Next Article in Journal
Diagnosing Lung Cancer: The Complexities of Obtaining a Tissue Diagnosis in the Era of Minimally Invasive and Personalised Medicine
Previous Article in Journal
Healing of Ischemic Colon Anastomosis in Rats Could Be Provided by Administering Dexpanthenol or Coenzyme Q10
Open AccessArticle

Morphogenetic Variability and Hypertension in Ischemic Stroke Patients—Preliminary Study

1
Special Hospital for Cerebrovascular Diseases “Sveti Sava”, Belgrade 11000, Serbia
2
Institute for Human Genetics, Faculty of Medicine, University of Belgrade, Belgrade 11000, Serbia
3
Faculty of Medicine, University of Belgrade, Belgrade 11000, Serbia
4
Institute for Rehabilitation, Belgrade 11000, Serbia
5
Department of Physical Medicine and Rehabilitation, University Children’s Hospital, Tirsova 10, Belgrade 11000, Serbia
*
Author to whom correspondence should be addressed.
J. Clin. Med. 2018, 7(7), 162; https://doi.org/10.3390/jcm7070162
Received: 23 May 2018 / Revised: 22 June 2018 / Accepted: 25 June 2018 / Published: 26 June 2018
(This article belongs to the Section Hematology)
In this study, we evaluated and compared the morphogenetic variability and the degree of recessive homozygosity in patients with manifested ischemic stroke compared to healthy controls. We have evaluated 120 patients with manifested ischemic stroke, of which 64 did not have hypertension and 56 have hypertension. For comparison, we additionally tested 194 healthy individuals without manifested ischemic stroke (controls). For the estimation of the degree of recessive homozygosity, we have performed the homozygously recessive characteristics (HRC) test and tested 19 HRCs. There was a significant difference in the individual variations of 19 HRCs between the controls and patients with manifested ischemic stroke (∑χ2 = 60.162, p < 0.01). The mean values of the tested HRCs significantly differed between the controls and group with manifested ischemic stroke (Controls − 5.71 ± 1.61, Ischemic stroke group − 6.25 ± 1.54, p = 0.012). For the tested individuals with hypertension, the mean values of HRCs did not significantly differ between the controls and those that had manifested ischemic stroke (Controls − 5.28 ± 1.75, Ischemic stroke group − 5.64 ± 1.48, p = 0.435). We found a significant difference in the frequencies of HRCs between those with and without hypertension for controls (p < 0.003) and for those with manifested ischemic stroke (p < 0.001). There are increased degrees of recessive homozygosity along with decreased variability in patients with manifested ischemic stroke compared to controls. View Full-Text
Keywords: manifested ischemic stroke; homozygous recessive characteristics; variability; hypertension manifested ischemic stroke; homozygous recessive characteristics; variability; hypertension
Show Figures

Figure 1

MDPI and ACS Style

Savic, M.; Cvjeticanin, S.; Lazovic, M.; Nikcevic, L.; Nikolic, D. Morphogenetic Variability and Hypertension in Ischemic Stroke Patients—Preliminary Study. J. Clin. Med. 2018, 7, 162.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop